Effects of Restricted-time and Psychochrononutritional Feeding in People With Metabolic Syndrome
PSICRONUT
Effect of a Restricted Time and Psychochrononutritional Feeding Intervention Program on the Nutritional Status of People With Metabolic Syndrome in Ciudad Guzmán
2 other identifiers
interventional
64
1 country
1
Brief Summary
Metabolic syndrome is a cluster of risk factors, including abdominal obesity, high blood pressure, high triglycerides, and insulin resistance, that increase the risk of developing type 2 diabetes and cardiovascular disease. The prevalence of this syndrome is rising in Mexico. Recent research suggests that when we eat is as important as what we eat. Therefore, chrononutritional strategies such as time-restricted eating (TRE), where food intake is confined to a specific daily time window, have been developed and shown promising benefits. However, there are documented barriers to maintaining this nutritional strategy over time. Therefore, this study proposes that combining TRE with a psychochrononutritional program (integrating psychological, chronobiological, and nutritional components) will improve adherence to the nutritional strategy and lead to better health outcomes than only prescribing a specific eating window. To this end, 64 adults (18-60 years old) with metabolic syndrome will be recruited in Ciudad Guzmán, Jalisco, Mexico. The TRE intervention will last eight weeks and include two groups. One group will undergo a psychochrononutritional intervention, whereas the other will receive only instructions regarding the eating window. Within each group, two subgroups will be formed: one assigned to an 8-hour eating window, and the other to a 10-hour window. Before and after the intervention, anthropometric, biochemical (lipid profile and plasma glucose), clinical (blood pressure), and dietary assessments will be performed. We expect reductions in blood pressure, glucose, triglycerides, and waist circumference as well as better adherence in the psychochrononutritional intervention group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 4, 2025
CompletedFirst Submitted
Initial submission to the registry
January 28, 2026
CompletedFirst Posted
Study publicly available on registry
February 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedFebruary 18, 2026
January 1, 2026
4 months
January 28, 2026
February 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Waist circumference
Waist circumference: A decrease in waist circumference is expected, ≤102 cm in men and ≤88 cm in women. Measured in centimeters using a measuring tape at the level of the navel, at the end of a normal exhalation.
At the beginning (week 1) and end of the intervention (week 8).
Changes in Blood Pressure
Blood Pressure: A decrease in blood pressure of ≤130/85 mmHg is expected. Measurement of systolic and diastolic blood pressure using a digital blood pressure monitor.
At the beginning (week 1) and end of the intervention (week 8).
Changes in Glucose
Glucose: A decrease in glucose level to \<110 mg/dL is expected. Measurement of fasting plasma glucose, measured through a venous blood sample obtained between 7:30 and 8:30 am and processed using an automated colorimetric method.
At the beginning (week 1) and end of the intervention (week 8).
Changes in HDL cholesterol
HDL cholesterol: An increase in its values is expected, with a normal range of \>40 mg/dL in men and \>50 mg/dL in woman. The increase will mean better cardiovascular outcomes. Measurement of HDL cholesterol measured through a venous blood sample obtained between 7:30 and 8:30 am and processed using an automated colorimetric method.
At the beginning (week 1) and end of the intervention (week 8).
Changes in triglycerides levels
Triglycerides: a decrease in values is expected, with a reference range \<150 mg/dL. The decrease will mean better cardiovascular outcomes. Measurement of serum triglycerides measured through a venous blood sample obtained between 7:30 and 8:30 am and processed using an automated colorimetric method.
At the beginning (week 1) and end of the intervention (week 8).
Treatment Adherence
Degree to which participants follow the recommendations of the intervention program, it will be measured by self-reporting. Adherence is expected four out of seven days a week.
Monitoring for 8 weeks.
Secondary Outcomes (5)
Changes in Body weight
At the beginning (week 1) and end of the intervention (week 8).
Body composition analysis
At the beginning (week 1) and end of the intervention (week 8).
Changes in visceral fat
At the beginning (week 1) and end of the intervention (week 8).
Mexican Diet Quality Index
At the beginning (week 1) and end of the intervention (week 8).
Sleep quality
At the beginning (week 1) and end of the intervention (week 8).
Study Arms (2)
Minimal intervention group
OTHERParticipants will be instructed to adhere to a specific eating window, with flexibility to select their daily eating-window start and end times, as long as they fall within an 8- or 10-hour period. This intervention will last 8 weeks, during which they are instructed to consume all their caloric intake within the established time window.
Grupo experimental
EXPERIMENTALParticipants will be instructed to adhere to an 8- or 10-hour eating window, with flexibility to select their daily eating-window start and end times but must concentrate their caloric intake within that period. Additionally, the group receives a psychochrononutritional intervention consisting of weekly group sessions with an educational and behavioral focus for 8 weeks.
Interventions
Behavioral and dietary intervention in which participants are instructed to consume all their food and caloric beverages within a fixed window (8 or 10 hours, depending on arm assignment). Outside of this window, only water or non-caloric beverages are permitted. The intervention will last 8 weeks.
Participants will receive a structured psychochrononutritional intervention consisting of eight weekly sessions. The program will cover the following topics: * Chrononutrition: The internal clock of eating. * Food groups and healthy menu planning. * Portion control: Learning to measure appropriately. * Effects of sugary drinks. * Sleep and its impact on eating habits. * Social and cultural factors in eating habits. * The relationship between physical activity and nutrition. * Making informed nutritional decisions.
Eligibility Criteria
You may qualify if:
- Age 18 to 60 years
- Both sexes
- Feeding window ≥14 h/day
- Usual sleep duration \>6.5 h
- Individuals diagnosed with metabolic syndrome who meet three or more of the criteria from Panel III of the National Cholesterol Education Program's Adult Treatment Guidelines:
- Waist circumference: ≥102 cm for men, ≥88 cm for women
- Triglycerides: ≥150 mg/dL or on treatment for hypertriglyceridemia
- High-Density Lipoprotein (HDL) cholesterol: \<40 mg/dL for men, \<50 mg/dL for women
- Blood pressure: systolic ≥130 mmHg and diastolic ≥85 mmHg or on treatment for hypertension
- Fasting plasma glucose: ≥100 mg/dL
- Individuals who provide informed consent
You may not qualify if:
- (based on participant self-report unless medical records are available)
- Pregnancy or lactation
- Currently enrolled in a weight loss program
- Current treatment with antidepressants, medications that affect glucose metabolism or appetite, or immunosuppressant therapy
- History or presence of eating disorders
- Sleep apnea
- Elimination Criteria:
- Participants who do not attend more than two sessions of the psychochrononutritional intervention program.
- Participants who decide to withdraw their consent to continue in the study at any time for any reason.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Universitario del Sur
Ciudad Guzmán, Jalisco, 49000, Mexico
Related Publications (1)
Manoogian ENC, Wilkinson MJ, O'Neal M, Laing K, Nguyen J, Van D, Rosander A, Pazargadi A, Gutierrez NR, Fleischer JG, Golshan S, Panda S, Taub PR. Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial. Ann Intern Med. 2024 Nov;177(11):1462-1470. doi: 10.7326/M24-0859. Epub 2024 Oct 1.
PMID: 39348690BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yadira V Martínez Vázquez, PhD students
University of Guadalajara
- STUDY CHAIR
Alma G Martínez Moreno, PhD
University of Guadalajara
- STUDY CHAIR
César A Gómez Acosta, PhD
Universidad de Pamplona
- STUDY CHAIR
Ana C Espinoza Gallardo, PhD
University of Guadalajara
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD- Research Professor
Study Record Dates
First Submitted
January 28, 2026
First Posted
February 5, 2026
Study Start
December 4, 2025
Primary Completion
April 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
February 18, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
For security and data protection reasons, access to participants' identities is restricted. Sharing identification forms with external researchers contradicts the principle of purpose limitation of consent, which stipulates that personal information will be treated anonymously and privately, ensuring that no data that could re-identify subjects is disclosed outside the authorized research team.